Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cell|March 20, 2012
Antibody-based immunotherapy of cancerLouis M Weiner, Joseph C Murray, Casey W Shuptrine
Pharmacoepidemiology and Drug Safety|February 17, 2025
Validation of Immune-Related Adverse Event (irAE) Case Definitions in a Real-World Lung Cancer PopulationJames S Heyward, Jodi B Segal, Hemalkumar B Mehta, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 23, 2025
Association Between Metformin Use and Mortality Among Individuals With Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: A Retrospective Cohort StudyXinyi Sun, James Heyward, Joseph C Murray, et al.
JAMA Oncology|May 8, 2025
Harm-Benefit Balance of Immune Checkpoint Inhibitors in Non-Small Cell Lung CancerJames Heyward, Catherine R Lesko, Joseph C Murray, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|December 18, 2025
Productivity of National Cancer Institute K Awardees and Their Transition to Independent FundingMariah Malak Bilalaga, Louay Almidani, Jehan Mousa, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 10, 2023
Antibody-Drug Conjugates for Lung Cancer: Payloads and ProgressSamuel Rosner, Augusto Valdivia, Hui Jing Hoe, et al.
Cancer Immunology Research|October 11, 2014
c-Abl modulates tumor cell sensitivity to antibody-dependent cellular cytotoxicityJoseph C Murray, Dalal Aldeghaither, Shangzi Wang, et al.
Clinical Lung Cancer|July 7, 2023
Infectious Complications in Patients With Non-small Cell Lung Cancer Treated With Immune Checkpoint InhibitorsMatthew Z Guo, Aanika Balaji, Joseph C Murray, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|June 12, 2025
An Implemented Real-World-Data Pipeline for Standardization of Electronic Health Records in Precision OncologyKory Kreimeyer, Durrant Barasa, Mohamed Sherief, et al.
Pageof 4